About this policy
CMS NCA document | source_status=Closed | review_type=1st Recon | public_comment_open=False | document_id=CAG-00157R
Coverage indications
CMS concludes that outside the covered indications it is appropriate to allow coverage of implantable defibrillators in accordance with the Category B IDE clinical trials regulation (42 CFR 405.201) or as a routine cost in clinical trials defined under the NCD Manual section 310.1. Therefore, CMS will allow coverage under these circumstances as outlined in the policy (NCD 20.4).
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.